Solid Tumor Recruiting Phase 1 Trials for Irinotecan (DB00762)

Also known as: Cancer - Solid Tumors / Solid Tumour / Solid Tumours / Tumor, Solid / Solid Neoplasms / Solid tumour/cancer / Solid Cancers / Cancer: Solid Tumors / Neoplasms, Solid Tumor / Cancer, Solid Tumor / Tumors, Solid / Solid Tumor Cancer / Solid Tumors or Cancers / Solid Tumors / Solid Neoplasm / Cancer (Solid Tumors) / Solid Tumor Neoplasms / Solid Tumor Cancers / Solid Cancer / Neoplasm / Neoplasm (morphologic abnormality) / Neoplasms of unspecified behavior / Neoplasms NOS / Neoplasms NOS (disorder) / [M]Neoplasms NOS (morphologic abnormality) / Neoplasm (NOS) / Tumor / Neoplasm NOS / Tumour / Tumour NOS / Neoplasms / Tumour, NOS / Tumor NOS / Neoplasm, NOS / Tumor, NOS / Neoplasms benign, malignant and unspecified (incl cysts and polyps)

IndicationStatusPhase
DBCOND0030180 (Solid Tumor)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05382559
A Study of ASP3082 in Adults With Advanced Solid TumorsTreatment
NCT05786924
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive MalignanciesTreatment
NCT04796012
VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid TumorsTreatment
NCT03866525
OH2 Oncolytic Viral Therapy in Solid TumorsTreatment
NCT06760117
UGT1A1 Genotype-drien Phase I Study of Irinotecan in VIT Regimen for the Treatment of Pediatric R/R Solid TumorsTreatment
NCT05381038
Optimizing and Personalising Azacitidine Combination Therapy for Treating Solid Tumours QPOP and CURATE.AITreatment
NCT06840886
A Study of PHST001 in Advanced Solid TumorsTreatment
NCT05592626
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid TumorsTreatment
NCT03526835
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid TumorsTreatment
NCT05719558
A Study of ASP1002 in Adults for Treatment of Solid TumorsTreatment
NCT06835569
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS MutationsTreatment
NCT06006273
A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in Children With Relapsed or Refractory Solid TumorsTreatment
NCT05978492
A Study of TXN10128 in Subjects With Solid TumorsTreatment
NCT06179160
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D MutationTreatment
NCT05836324
A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid TumorsTreatment
NCT06621563
Phase Ib Trial of HS-20117 in Combination With Other Drugs in Advanced Solid TumorsTreatment
NCT06047379
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain MetastasisTreatment
NCT04901702
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing SarcomaTreatment
NCT06208657
Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent CancerTreatment